Swedish Orphan Biovitrum AB (publ) provided revenue guidance for the year 2024. For the period, the company anticipated revenue to grow by a high single-digit percentage at CER.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
280 SEK | 0.00% | -0.36% | +4.87% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.87% | 8.81B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
-4.33% | 8.5B | |
-3.94% | 7.26B |
- Stock Market
- Equities
- SOBI Stock
- News Swedish Orphan Biovitrum AB
- Swedish Orphan Biovitrum AB Provides Revenue Guidance for the Year 2024